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Background
There is growing epidemiological evidence of the harm caused to health by
tobacco smoking. The data can be used to calculate the economic impact of
tobacco use. In Hong Kong, information is available on the impact of tobacco
use on mortality and also on the impact of passive smoking on health care
utilisation and on time taken off work by those exposed to second-hand smoke
(SHS). Using this and other data we calculated the annual health-related cost of
tobacco smoking, with 1998 as the example year.
Aim
This study aimed to estimate the costs of tobacco-related disease in 1998 using
local data.
Methods
This study was conducted from May 2000 to May 2003.
Data
Data were used to estimate the cost of in-patient and out-patient use of health
care, in both public and private sectors, which could be related to tobacco use.
This covered the effects of both active and passive smoking.
The datasets used included: the lifestyle and mortality study (LIMOR), which
provided relative risks of active and passive smoking on mortality from a variety
of causes1; the Harvard Household Survey (HHS), which provided population
data on active and passive smoking and on health care utilisation2; the Police
Health Survey (PHS), which provided data on the association between passive
smoking and health care utilisation and time off work3; and the Hospital
Authority (HA) in-patient database, which covers all episodes of hospital care in
public hospitals.
Mortality due to active smoking
Analysis of the LIMOR dataset indicated the risks of excess mortality from
specific causes for smokers.4 The dataset was reanalysed to calculate the fraction
of deaths attributed to active smoking. Applying these attributable fractions to
all deaths, we estimated the number of lives lost, premature lives lost (ie those
<75 years), and lives lost during productive years (ie those <65 years). Using the
age at death, we calculated life years lost before age 75 and productive years
lost. Life years were discounted at 3% per annum. The losses were monetised by
valuing a premature life lost at HK$10 million and a working year lost at the
median wage in 1998 for male or female, as appropriate.
Morbidity due to active smoking
We applied the disease-specific attributable fractions for mortality to hospital
admissions, assuming that the proportion of all those who died of a specific
disease was similar to the proportion of all those admitted for that disease.
Specialist out-patient visits were analysed in a similar manner. The HA
provided data on the unit cost of a bed-day in acute and long-stay hospitals and
unit costs of a specialist out-patient visit. For private hospitals, we used data
on the number of admissions. BUPA (Asia) Ltd supplied an estimate of charges
for admissions that gave a conservative estimate of the cost of private hospital
care.
Key Messages
1. Tobacco use costs Hong Kong
more than $5.3 billion (bn) per
year (estimated from 1998 data).
2. Two thirds of the cost ($3.6 bn)
was for health care and the
remainder ($1.8 bn) was for
productivity losses due to ill
health or death during working
life. The proportion of the
morbidity costs which fell on the
public sector was 70% for active
smoking and 50% for passive
smoking.
3. Much of the enormous annual
cost  f rom tobacco use is
avoidable.
4. Legislation preventing smoking
in public places would reduce
much of the expenditure on
passive and some of that on
active smoking effects.
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Less severe morbidity could be treated by general
out-patient clinics (GOPCs), Accident and Emergency
(A&E) units, or by private general practitioners (GPs). For
GOPCs, we applied the attributable risks calculated from
LIMOR to the total number of GOPC visits and multiplied
the value obtained by the unit cost of a visit. For private GP
visits, we included only visits for respiratory disease and
used an estimate of relative risk for a smoker from a local
study.5 This relative risk was applied to an estimate of all
visits for respiratory problems and the average cost of these
visits taken from the HHS.
The relative risk of taking extra time off work due to
active smoking was estimated using the PHS data. An
attributable fraction was then applied to a conservative
estimate of the days taken off work by the working
population and the days lost were valued at the median
wage. Similarly, the days spent in hospital as an in-patient
by those of working age was adjusted to reflect the non-
working population and multiplied by the median wage.
Those who suffer from tobacco-related diseases may use
other services such as long-term care, that is residential care
including nursing homes or may be looked after at home by
a domestic helper or family members. We estimated these
costs based on the number of smoking attributable cases of
disease identified. The number of persons enrolled in the
four types of residential care home was obtained from
routine data (personal communication). The unit monthly
cost for each kind of residential care home (personal
communication) was multiplied by the attributable number
of cases to get the annual smoking attributable nursing home
cost. We used the amount of time over which persons
required home-based care from the LIMOR dataset and
applied it to the costs of local and foreign domestic helpers6
to calculate the attributable cost for decedents in their last
year of life. We did not attribute any cost to those looked
after by family members due to the lack of suitable cost
data.
Mortality due to passive smoking
Passive smoking has been associated with lung cancer,
chronic obstructive pulmonary disease (COPD), ischaemic
heart disease (IHD), and stroke in both local and
international studies. We used the locally derived relative
risks for lung cancer, COPD, and stroke and the overseas
pooled results for IHD, which were very similar to the local
findings. We estimated attributable fractions of mortality
from these causes and valued them in dollars in the same
way as for active smoking. In the main estimate of cost, we
included the impact of passive smoking at home and at
work. The costs were calculated for all non-smokers.
Morbidity due to passive smoking
Local data on the costs in the first year of life due to
pre- and post-natal passive smoke exposure are available.7
From another local study on 8- to 12-year-old children,8
we extrapolated the excess doctor visits caused by passive
smoking and their costs to children between 1 to 15 years
old. Local data on the levels of the nicotine metabolite
cotinine in catering workers has been used to model the
likely mortality from lung cancer and heart disease in this
occupational group.9 For the remainder of the population,
we applied the attributable fractions for mortality to
admissions for lung cancer, COPD, IHD, and stroke. We
did not include the cost of private hospitals due to lack of
data.
For more minor morbidity, we used local data on
self-reported use of GP services and their costs for those
exposed to SHS at work.10 We could not include the impact
of SHS at home due to insufficient data.
We estimated time lost due to passive smoking from a
published paper11 using the PHS dataset, but recalculated it
to give sex-specific estimates. We also included an estimate
of the time lost due to the attributable inpatient admissions
for the working population.
All reported costs are in Hong Kong dollars
(HK$7.8=US$1.0) and are for 1 year (1998).
Results
The Table shows the costs of active and passive smoking.
We estimate that 5596 deaths (aged ≥35 years) in Hong
Kong in 1998 were attributable to active smoking and 3398
(61%) of these are premature deaths (<75 years). The
number of deaths occurring while smokers or ex-smokers
were in their productive years (<65 years) was 1529 (27%
of all attributable deaths).
The smoking-attributable years of potential life lost for
all premature deaths was 28 668 years with a 3% discount
rate. This is 8.4 years for each smoking-attributable
premature death. Assuming that the production of a person
not in the work force is zero, the attributable productive years
lost was 8669 person years with a 3% discount rate.
Value of mortality attributable to active smoking
Applying the value of $10 million to each premature life
lost, we obtain a value of $33 980 million. The monetary
value of the lost productive years was $1244 million,
valued at the median wage.
Morbidity due to active smoking
The smoking-attributable cost of public acute and long-stay
hospital care was $1314 million. This was about 5% of the
HA’s total expenditure in 1998.
The estimated annual cost of private hospital utilisation
attributable to active smoking was $124 million.
Smoking-attributable visits to an HA specialist out-
patient clinic (SOPC) numbered 256 823 with a cost of $148
McGhee et al
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million, representing 5.2% of all visits to non-paediatric
SOPCs.
The cost of the 714 585 attributable attendances at
GOPCs was estimated to be $160 million; this was 11.7%
of the total cost for GOPC visits in 1998. If we assume
that the average public sector doctor sees 30 patients a day
5 days a week for 48 weeks per year, then the smoking-
attributable visits represent the workload of 99 full-time
doctors in GOPCs.
There were 105 661 smoking-attributable visits to A&E
units costing $60 million. This amounts to 4.6% of the total
A&E visits in 1998.
The cost of the 519 962 attributable GP consultations
for respiratory disease in 1998 was $94 million. The
attributable visits were 2.9% of total doctor consultations
for respiratory disease in 1998. If we assume each GP sees
30 patients per day 5 days a week for 48 weeks per year,
these consultations are equivalent to the workload of 72
full-time GPs.
Absence for illness or injury due to active smoking
number was estimated to be 192 503 days. Of these, 116 590
days may be due to admissions into public hospitals.
Valued at the median monthly wage, this was $74 million.
This did not include the cost of time off for doctor
consultations or a period of suboptimal productivity on
return to work.
The attributable cost of nursing home care due to active
smoking was $913 million while the cost of home-based
care was $5 million.
Morbidity due to passive smoking
Extra hospitalisations and out-patient consultations due
to SHS exposure in utero and post-natally at home
resulted in an annual cost of $27.1 million.7 Extrapolating
this number to all children aged 1 to 15 in Hong Kong
gave an estimate of $6.2 million for extra doctor visits for
children.
Public hospital use for lung cancer, COPD, IHD, and
stroke attributable to passive smoking costed a total of $471
million for home or work exposure.
For the three million full-time workers, there were
Table.  Summary of the annual costs (1998) of mortality and morbidity due to diseases caused by tobacco
Component of cost No. of smoking Unit cost (HK$) Value
attributable units (million HK$)
Active Passive Active smoking Passive smoking Active Passive
smoking smoking smoking smoking
Mortality
Total lives lost 5596 1324 - - - -
Premature deaths (<75 years) 3398 529 10 million 10 million 33 980 5290
Productive lives lost (<65 years) 1529 178 - - - -
Life years lost (<75 years) 28 668 3719 - - - -
Productive years lost (<65 years) 8669 815 male: 144 000, male: 144 000, 1244 109
female: 108 000 female: 108 000
Morbidity
Admissions and outpatient use in children - 33
Public hospital days
Acute 270 038 88 916 3744 3744 1011 333
Long stay 152 888 69 588 1985 1985 303 138
Private hospital episodes 6370 NE* 19 500 on NE 124 -
average
Specialist out-patient clinics (visits) 256 823 NE 578 NE 148 -
General out-patient clinics (visits) 714 585 NE DH: 218, NE 160 -
HA†: 265
Accident & emergency (visits) 105 661 NE 572 NE 60 -
Private general practitioner (visits) 519 962 approx 181 181 94 248
1 500 000
Days off work (private sector) 170 893 942 409 male: 395, male: 395, 66 319
Days off work (public sector) 21 610 102 390 female: 296 female: 296 8 35
Nursing home care 913 -
Home-based care 5 2
Sub-total component of cost Active smoking Passive smoking
Health care HK$1 900 000 000 HK$752 000 000
Residential and informal care HK$918 000 000 HK$2 000 000
Lost working time HK$1 310 000 000 HK$463 000 000
Deaths (all ages) 5596 1324
Deaths (<75 years) 3398 529
Sub-total annual costs HK$4.1 billion plus the value of lives lost HK$1.2 billion plus the value of lives lost
Total annual costs HK$5.3 billion plus the value of lives lost of 6920 (3927 of them premature) deaths
* NE denotes not estimated
† DH denotes Department of Health, and HA Hospital Authority
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around 1.5 million extra visits to a doctor for cold, flu, or
fever, which were attributable to SHS exposure at work.
The cost was $248 million with $21 million (8.5%)
attributed to the public sector, $71 million (28.6%) paid
for by the employer, and $156 million (62.9%) paid by the
employees themselves. We do not have data for home
exposure effects on GP visits.
After applying the population attributable fraction to
the total number of days off, we estimate an attributable
loss of 1 044 799 days per year. Applying the median salary,
exposure to SHS at work for the labour force in 1998 cost
$354 million. The value of attributable work days lost due
to hospital admissions amounted to $7.2 million for SHS
exposure at home or at work.
The attributable cost of home-based care due to passive
smoking was $2 million but we could not estimate the cost
of nursing home care for conditions caused by passive
smoking.
Conclusions
A conservative estimate of the cost of smoking in Hong
Kong in 1998 is $3.6 billion for health care and $1.8
billion for productivity losses. About 3927 people died
prematurely in that year. Of the morbidity costs, 70% and
50% for active and passive smoking respectively were
incurred in the public sector. About 23% of the total
annual costs is due to passive, rather than active, smoking.
Of the productivity losses, 26% was due to passive
smoking with most of this effect likely to be due to passive
smoking at work. This costing has not included the cost
of intensive care or coronary care, or pain and suffering
due to illness.
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